Next ACTIP meeting
Considering the remaining travel restrictions due to the COVID-19 pandemic, the ACTIP steering committee has decided to change the face-to-face ACTIP meeting in Neuchâtel, Switzerland to a virtual meeting in the afternoon of Thursday, 12 November 2020.
The two scientific sessions will cover: “Advanced bioprocess development and control strategies” and “Speed to clinic: how to accelerate process development between drug discovery and clinical trials”.
The meetings are for ACTIP members and individually invited guests. More information can be obtained via: firstname.lastname@example.org
News from ACTIP
Due to the COVID-19 pandemic and related travel restrictions, the 6-8 May 2020 ACTIP meeting in Madrid, Spain has been postponed to Spring 2021.
ACTIP awards 9 training grants to young scientists to attend the virtual ESACT Animal Cell Technology Course
After a selection process by the ACTIP steering committee, ACTIP has awarded 9 training grants to young scientists from industry and academia to attend the virtual ESACT Animal Technology Course taking place from 21-25 September 2020. As a remembrance of winning the grant, ACTIP will hand out a book about animal cell technology to each of the winners.
The Animal Cell Technology Industrial Platform (ACTIP)
ACTIP is an informal forum of European companies with significant activities in animal cell technology. See also ACTIP Information Paper. Its objectives include networking and following cutting-edge developments in research and production related to animal cell technology. Topics covered include the production of biopharmaceuticals, monoclonal antibodies, vaccines, gene therapy vectors and safety testing.
ACTIP’s members meet twice a year in a plenary meeting, hosted in the home-town of a member company. These meetings feature high-level presentations on selected topics, with invited speakers from academia, our own member companies and small and medium-sized companies (SMEs). In addition to our meetings, we prepare position papers, monographs, information on products and a regular newsbulletin (see library page).